South African drugmakers want more time to comment of price benchmarking
14 September 2008
The Department of Health in South Africa has said it intends to implement a methodology for international benchmarking of originator drug prices, and has invited comment from interested parties, giving a 30-day deadline for them to do so.
The proposed framework for international benchmarking says originator drug companies should drop their prices to the lowest level in a selected basket of countries, which includes Australia, Canada, New Zealand, South Africa and Spain.
The Pharmaceutical Task Group has written to the Department of Health, asking for the comment period to be extended to the end of next month. The Department's head of pharmaceutical and economic planning, Anban Pillay, said a decision had yet to be taken on whether to grant the extension to the group, an umbrella body for the nation's five key industry associations for pharmaceutical firms. It includes Innovative Medicines of SA, the Pharmaceutical Industry Association of SA (Piasa), the National Association of Generic Manufacturers, Pharmaceuticals Made in SA and the Self-Medication Manufacturers Association of SA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
South African drugmakers want more time to comment of price benchmarking
The Department of Health in South Africa has said it intends to implement a methodology for international benchmarking of originator drug prices, and has invited comment from interested parties, giving a 30-day deadline for them to do so.
The proposed framework for international benchmarking says originator drug companies should drop their prices to the lowest level in a selected basket of countries, which includes Australia, Canada, New Zealand, South Africa and Spain.
The Pharmaceutical Task Group has written to the Department of Health, asking for the comment period to be extended to the end of next month. The Department's head of pharmaceutical and economic planning, Anban Pillay, said a decision had yet to be taken on whether to grant the extension to the group, an umbrella body for the nation's five key industry associations for pharmaceutical firms. It includes Innovative Medicines of SA, the Pharmaceutical Industry Association of SA (Piasa), the National Association of Generic Manufacturers, Pharmaceuticals Made in SA and the Self-Medication Manufacturers Association of SA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
Become a subscriber
£820
Or £77 per month
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze